WASHINGTON, D.C. – An FDA panel has given the green light to what would be the nation’s first anti-viral pill to fight COVID-19 in high-risk adults. On November 30, the FDA’s Antimicrobial Drugs Advisory Committee voted 13-10 in favor of ...
READINGTON, N.J. (NBC) – The drugmaker Merck says its experimental COVID-19 pill is not as effective as previously reported. New data from its study shows the pill can reduce hospitalizations and deaths by 30% down from 50% reported last month. ...